Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-33

Let's be patient and optimistic that Biotron can come up with something Phenomenal, leading to SP of around $0.88/s.

Let's appreciate the non-holders to be critical becasue Biotron lacks of sense of Urgency to prepare the paperworks and attract Australian Govt and/or potential partners' active support....

Let us all (holder and non-holder) appreciate Biotron to
* present 2-year-hatched Covid Trial outcomes.
* confidently Running Four HIV Trials which are supposed to

Let us all (holders and non-holders) encourage MM to find potential non-equity fundings